Weighted-Average Shares Outstanding (Basic): The number of shares held by shareholders including insiders but not including a company's treasury shares, sourced from the company 10-K or 10-Q SEC reports.
Avidity Biosciences, Inc. (RNA) had Weighted-Average Shares Outstanding (Basic) of 137.90M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$12.47M |
|
$-174.44M |
|
-- |
|
$12.47M |
|
$201.28M |
|
$-188.81M |
|
$14.36M |
|
$-174.44M |
|
$-174.44M |
|
$-174.44M |
|
$-174.44M |
|
$-174.44M |
|
$-174.44M |
|
$-188.81M |
|
$-190.16M |
|
|
Weighted-Average Shares Outstanding (Basic) |
137.90M |
137.90M |
|
$-1.27 |
|
$-1.27 |
|
| Balance Sheet Financials | |
$1.97B |
|
$21.50M |
|
$168.19M |
|
$2.13B |
|
$169.88M |
|
-- |
|
$78.06M |
|
$247.94M |
|
$1.89B |
|
$1.89B |
|
$1.89B |
|
146.77M |
|
| Cash Flow Statement Financials | |
$-480.67M |
|
$-245.25M |
|
$856.08M |
|
$222.66M |
|
$352.96M |
|
$130.29M |
|
$54.42M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.57 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-1513.47% |
|
-1513.47% |
|
-- |
|
-1398.33% |
|
-1398.33% |
|
$-491.65M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-9.25% |
|
-9.25% |
|
-8.17% |
|
-9.25% |
|
$12.85 |
|
$-3.57 |
|
$-3.49 |
|